Fig. 3From: Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a case reportSummary of the disease course and the treatment process. The patient was subjected to third-line therapy and OS was found to be 21Â months. PD: Progressive Disease; PFS: Progression-free survival; OS: Overall survivalBack to article page